Gilead, Goldfinch to team up against kidney disease
The multi-year collaboration will expand the scope of Goldfinch’s proprietary Kidney Genome Atlas.
9th May 2019
Latest news
AZ, Daiichi HER-2 drug shows promise in mid-stage trial
Approximately one in five breast cancers are HER2-positive, meaning there is an unmet need for treatments.
9th May 2019
Eisai, Dementia Research Institute join forces for research
The collaboration will draw together world-leading expertise into a single national institute that conducts research into all aspects of dementia including Alzheimer's disease.
9th May 2019
Ocrevus finally available on NHS
The availability of Ocrevus has been branded a “landmark moment” by the MS Society.
9th May 2019
Waylivra granted conditional marketing authorisation in Europe
The authorisation follows the positive opinion recommending approval provided by the Committee for Medicinal Products for Human Use (CHMP).
8th May 2019
AMR could cause 10 million deaths per year by 2050
The disease that causes one-third of all AMR related deaths - drug-resistant tuberculosis (DR-TB) - is rarely talked about.
8th May 2019
Pfizer's Vyndaqel, Vyndamax win US nod for rare disease
The approval is based on a clinical trial which showed that after an average of 30 months, the survival rate was higher in the Vyndaqel group.
8th May 2019
EU approval for Palynziq in adult phenylketonuria
It's the first substitution therapy approved in Europe to target the underlying cause of PKU by helping the body to break down Phe.
8th May 2019
AZ’ Calquence trial to stop early after hitting endpoints
The drug was found to significantly increase the time patients live without disease progression.
8th May 2019
Final week to book tickets for the International Clinical Researcher of the Year awards ceremony!
We are now approaching the final week to book tickets for the 2019 PharmaTimes international Clinical Researcher of the Year gala dinner & awards ceremony.
7th May 2019
FDA approves Ruzurgi for children with Lambert-Eaton myasthenic syndrome
The FDA has also granted the application Priority Review and Fast Track designations.
7th May 2019
Prostate cancer mutation found to triple risk of death
The research also identified clues for how some patients with prostate cancer could be treated more effectively using immunotherapy and a breast cancer treatment.
7th May 2019
Vectura wins patent litigation battle against GSK, awarded $89.7M
The companies had entered into an agreement in 2010 under which GSK had taken a license to formulation technology covered by a Vectura patent family.
7th May 2019
Roche launches HER2 biomarker test for breast and gastric cancer
The test “advances Roche’s commitment to personalised healthcare".
7th May 2019
FDA hits Acacia with another rejection, cites manufacturer issues
The same issue was raised initially in October 2018.
7th May 2019
